BioScience Health Innovations Growth Metrics (2020-2025) | BHIC

Growth Metrics Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) 150.17%-69.98%-98.36%-69.39%379.45%2,883.93%6,439.04%157.41%-70.52%465.45%239.21%337.71%835.65%801.15%863.24%397.10%
Assets Growth (3y) 52.35%
Assets (QoQ) -0.95%188.12%-9.81%-2.80%-88.12%-84.31%1,588.24%1,422.55%-26.03%-65.61%-33.54%74.39%130.01%50.87%-1.70%65.76%37.98%94.69%110.13%59.65%47.49%0.47%
Cash & Equivalents Growth (1y) -9.18%-98.36%-90.14%379.45%2,883.93%6,439.04%698.67%-70.52%881.98%374.72%693.61%3,343.79%1,006.52%802.86%241.94%
Cash & Equivalents (QoQ) 771.72%-9.81%-2.80%-88.12%-84.31%444.12%4,624.03%-26.03%-65.61%-33.54%74.39%220.34%38.50%-54.18%383.08%54.86%131.53%98.82%55.22%26.36%-12.31%
Cash from Investing Activities (QoQ) -170.00%-57.89%46.45%
Cash from Operations Growth (1y) 90.55%-397.49%30.41%-175.79%-920.93%-41.65%-372.97%27.95%160.61%174.22%10.90%783.41%311.27%-751.78%
Cash from Operations Growth (3y) -65.88%
Cash from Operations (QoQ) 197.12%-177.64%37.22%80.03%-2,956.75%81.84%-148.80%26.09%-324.11%-71.48%38.45%19.78%14.91%244.25%-24.63%-196.31%752.64%-13.19%-219.45%
EBITDA Margin Growth (1y) 19,946.0014,206.003,955.001,427.005,401.00672.00-1059.00
EBITDA Margin (QoQ) 9,594.009,300.001,710.00-659.003,855.00-951.00-818.003,315.00-874.00-2682.00
EBIT Growth (1y) -557.74%-12.16%-43.52%-152.58%-107.14%-1,392.18%10.76%-105.25%24.51%187.05%198.35%125.95%899.53%516.67%-115.63%
EBIT Margin Growth (1y) 19,946.0014,206.003,955.001,427.005,401.00672.00-1059.00
EBIT Margin (QoQ) 9,594.009,300.001,710.00-659.003,855.00-951.00-818.003,315.00-874.00-2682.00
EBIT (QoQ) -48.55%-1.19%-92.68%-127.11%74.67%-29.48%-239.09%-86.24%-82.48%92.26%-679.85%-20.57%32.98%32.85%-39.10%239.04%-24.28%-82.28%4,186.41%7.24%-101.92%
EBT Growth (1y) -557.74%-12.16%-43.52%-152.58%-38.36%-1,392.18%10.76%-105.25%24.51%187.05%198.35%125.95%899.53%516.67%-115.63%
EBT Margin Growth (1y) 19,946.0014,206.003,955.001,427.005,401.00672.00-1059.00
EBT Margin (QoQ) 9,594.009,300.001,710.00-659.003,855.00-951.00-818.003,315.00-874.00-2682.00
EBT (QoQ) -48.55%-1.19%-92.68%-127.11%74.67%-29.48%-239.09%-24.40%-173.20%92.26%-679.85%-20.57%32.98%32.85%-39.10%239.04%-24.28%-82.28%4,186.41%7.24%-101.92%
Enterprise Value Growth (1y) 9.18%98.36%90.14%-379.45%-2,883.93%-6,439.04%-698.67%70.52%-881.98%-374.72%-693.61%-3,343.79%-1,006.52%-802.86%-241.94%
Enterprise Value (QoQ) -771.72%9.81%2.80%88.12%84.31%-444.12%-4,624.03%26.03%65.61%33.54%-74.39%-220.34%-38.50%54.18%-383.08%-54.86%-131.53%-98.82%-55.22%-26.36%12.31%
EPS (Basic) Growth (1y) -249.69%16.57%0.31%-152.58%-38.36%-1,392.18%10.76%-105.25%74.72%183.38%806.31%120.89%875.40%460.43%-108.00%
EPS (Basic) (QoQ) -6.17%-8.36%-33.84%-127.11%74.67%-29.48%-239.09%-24.40%-173.20%92.26%-679.85%58.05%33.84%19.72%-13.47%238.36%460.43%-97.63%4,111.51%0.00%-108.00%
EPS (Weighted Average and Diluted) Growth (1y) 806.31%120.68%875.40%466.09%-107.70%
EPS (Weighted Average and Diluted) (QoQ) 19.72%-13.47%236.98%466.09%-97.65%4,153.69%0.00%-107.70%
FCF Margin Growth (1y) 18,888.0018,263.004,574.001,035.004,406.00-182.00-3921.00
FCF Margin (QoQ) 4,159.0012,797.001,803.00129.003,534.00-892.00-1736.003,500.00-1054.00-4631.00
Free Cash Flow Growth (1y) 90.55%-397.49%30.41%-175.79%-920.93%-41.65%-372.97%27.95%160.61%174.22%10.90%783.41%311.27%-751.78%
Free Cash Flow Growth (3y) -65.88%
Free Cash Flow (QoQ) 197.12%-177.64%37.22%80.03%-2,956.75%81.84%-148.80%26.09%-324.11%-71.48%38.45%19.78%14.91%244.25%-24.63%-196.31%752.64%-13.19%-219.45%
Gross Margin Growth (1y) -75.00-553.00-931.00-2234.00-1154.00-1965.00-1242.00
Gross Margin (QoQ) 100.00-289.00-554.00667.00-378.00-666.00-1857.001,748.00-1189.0057.00
Gross Profit Growth (1y) 750.87%417.59%164.90%43.34%281.72%246.19%64.39%
Gross Profit (QoQ) 117.34%167.38%47.51%-0.74%32.21%36.85%-20.18%164.34%19.90%-35.02%
Net Cash Flow Growth (1y) -773.32%-109.92%173.99%16,380.10%-41.65%-87.15%3,601.05%144.51%1,521.95%1,547.46%396.39%431.64%-184.51%
Net Cash Flow (QoQ) 671.72%-111.09%74.25%-2,956.75%88.63%182.68%5,565.20%-126.60%1,090.64%-44.03%-294.93%423.94%-30.82%271.27%73.96%11.09%-25.90%-159.02%
Net Income Growth (1y) -557.74%-12.16%-43.52%-152.58%-38.36%-1,392.18%10.76%-105.25%24.51%187.05%198.35%125.95%899.53%516.67%-115.63%
Net Income (QoQ) -48.55%-1.19%-92.68%-127.11%74.67%-29.48%-239.09%-24.40%-173.20%92.26%-679.85%-20.57%32.98%32.85%-39.10%239.04%-24.28%-82.28%4,186.41%7.24%-101.92%
Net Income towards Common Stockholders Growth (1y) -557.74%-12.16%-43.52%-152.58%-38.36%-1,392.18%10.76%-105.25%24.51%187.05%198.35%125.95%899.53%516.67%-115.63%
Net Income towards Common Stockholders (QoQ) -48.55%-1.19%-92.68%-127.11%74.67%-29.48%-239.09%-24.40%-173.20%92.26%-679.85%-20.57%32.98%32.85%-39.10%239.04%-24.28%-82.28%4,186.41%7.24%-101.92%
Net Margin Growth (1y) 19,946.0014,206.003,955.001,427.005,401.00672.00-1059.00
Net Margin (QoQ) 9,594.009,300.001,710.00-659.003,855.00-951.00-818.003,315.00-874.00-2682.00
Operating Income Growth (1y) -557.74%-12.16%-43.52%-152.58%-107.14%-1,392.18%-105.25%24.51%187.05%198.35%125.95%899.53%516.67%-115.63%
Operating Income (QoQ) -48.55%-1.19%-92.68%-127.11%74.67%-29.48%-239.09%-86.24%-82.48%-20.57%32.98%32.85%-39.10%239.04%-24.28%-82.28%4,186.41%7.24%-101.92%
Operating Margin Growth (1y) 19,946.0014,206.003,955.001,427.005,401.00672.00-1059.00
Operating Margin (QoQ) 9,594.009,300.001,710.00-659.003,855.00-951.00-818.003,315.00-874.00-2682.00
Profit After Tax Growth (1y) -557.74%-12.16%-43.52%-152.58%-38.36%-1,392.18%10.76%-105.25%24.51%187.05%198.35%125.95%899.53%516.67%-115.63%
Profit After Tax (QoQ) -48.55%-1.19%-92.68%-127.11%74.67%-29.48%-239.09%-24.40%-173.20%92.26%-679.85%-20.57%32.98%32.85%-39.10%239.04%-24.28%-82.28%4,186.41%7.24%-101.92%
Return on Assets Growth (1y) -731.00-1.00167.001,591.00357.00-373.00354.00377.00319.00280.00239.0096.0031.00
Return on Assets (QoQ) -30.00-149.00-1552.001,001.00699.0020.00-128.00-234.00-31.00125.00111.0039.0078.00148.0053.001.0037.005.00-12.00
Return on Equity Growth (1y) -292.0019.002,589.00-611.00-992.00-379.00-909.00-312.00-1047.0027,322.00487.00113.0038.00
Return on Equity (QoQ) -663.00-2517.002,995.00-107.00-352.0053.00-204.00-489.00261.00-213.00797.00-28368.0026,874.00384.0063.001.0040.0010.00-12.00
Return on Sales Growth (1y) 199.00142.0040.0014.0054.007.00-11.00
Return on Sales (QoQ) 96.0093.0017.00-7.0039.00-10.00-8.0033.00-9.00-27.00
Revenue Growth (1y) 758.46%453.04%198.17%100.98%342.03%357.47%97.47%
Revenue (QoQ) 114.82%176.64%58.00%-8.57%38.39%49.15%6.50%101.09%43.22%-35.62%
Shareholder's Equity Growth (1y) 281.05%-20,776.92%45.03%-199.80%909.93%1,124.17%189.24%212.52%-65.16%229.07%448.52%4,204.62%12,455.62%998.77%809.53%362.07%
Shareholder's Equity Growth (3y) 137.57%
Shareholder's Equity (QoQ) -101.37%-60,334.62%181.58%-43.52%-174.97%-59.12%-48.11%671.60%-23.97%-86.13%86.73%77.00%39.04%115.86%-178.59%1,799.10%64.62%95.83%125.57%51.10%36.27%-0.51%
Total Debt Growth (1y) 130.61%126.90%157.80%123.10%23.57%-79.49%-82.47%
Total Debt (QoQ) 1.64%2.99%22.03%80.54%0.00%17.02%5.60%0.00%-83.40%0.00%